19 results
424B5
OCUP
Ocuphire Pharma Inc
14 Aug 23
Prospectus supplement for primary offering
8:00am
that its timing and enrollment assumptions are correct given the above factors. The recent COVID-19 pandemic may also increase the time required to recruit … to commercialize its product candidates on its own include:
the inability to recruit and retain adequate numbers of effective sales and marketing personnel
424B5
OCUP
Ocuphire Pharma Inc
7 Jun 21
Prospectus supplement for primary offering
4:21pm
and enrollment assumptions are correct given the above factors. The recent COVID-19 pandemic may also increase the time required to recruit patients … product candidates on its own include:
the inability to recruit and retain adequate numbers of effective sales and marketing personnel or enter
8-K
EX-99.2
hn4ux3bmd vhd8kg356
15 Mar 21
Regulation FD Disclosure
9:00am
424B5
dehx2 7foxzd
11 Mar 21
Prospectus supplement for primary offering
9:19am
8-K
EX-99.1
a17fpv ot9e
11 Mar 21
Ocuphire Announces Financial Results for the Full Year 2020 and Provides Corporate Update
9:12am
424B4
6vu8qf4p
17 Feb 21
Prospectus supplement with pricing info
7:14am
424B3
bodnlstysavjc
2 Oct 20
Prospectus supplement
9:25am
S-4/A
hazp588ohwvc2
27 Aug 20
Registration of securities issued in business combination transactions (amended)
5:04pm
S-4
wqafi3k3vmp7o591qxk
6 Jul 20
Registration of securities issued in business combination transactions
4:08pm
10-K
69j0ns7t97cmrd
16 Mar 09
Annual report
12:00am
- Prev
- 1
- Next